Long-term effect of a single dose of flunarizine in Huntington's disease

被引：2
|
作者：
Belfiore, G
Di Maio, L
Napolitano, G
Cella, S
Filla, A
De Michele, G
Campanella, G
机构：
[1] Univ Naples Federico II, Neurol Clin, Dept Neurol Sci, I-80131 Naples, Italy
[2] Osped Civile Vito Fazzi, Dept Neurol, Lecce, Italy
[3] Mediterranean Neurol Inst NEUROMED, Pozzilli, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 1998年 / 5卷 / 03期
关键词：
Huntington's disease; flunarizine therapy;
D O I：
10.1046/j.1468-1331.1998.530249.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We report a preliminary pilot study on the clinical efficacy of flunarizine (FNZ), a calcium-entry blocker that causes extrapyramidal side-effects, in 10 patients with Huntington's disease (HD). FNZ (20 mg) administered by the sublingual route resulted in a decrease in choreic movements and improved dexterity in performing several tests. These effects lasted for at least 7 days after a single dose. Therefore, FNZ seems to exert the same effect as a long-acting neuroleptic agent in our HD patients. (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码：249 / 253
页数：5
相关论文
共 50 条
  • [1] Flunarizine in Huntington's disease
    Diener, HC
    PSYCHOPHARMAKOTHERAPIE, 1999, 6 (02): : 76 - 77
  • [2] The Long-term Effect of Tetrabenazine in the Management of Huntington Disease
    Fasano, Alfonso
    Cadeddu, Federica
    Guidubaldi, Arianna
    Piano, Carla
    Soleti, Francesco
    Zinzi, Paola
    Bentivoglio, Anna Rita
    CLINICAL NEUROPHARMACOLOGY, 2008, 31 (06) : 313 - 318
  • [3] Long-term effects of olanzapine in Huntington's disease
    Wheelock, V
    Tempkin, T
    MOVEMENT DISORDERS, 2005, 20 : S10 - S10
  • [4] The long-term safety of deutetrabenazine for chorea in Huntington's disease
    Frank, S.
    Vaughan, C.
    Stamler, D.
    Oakes, D.
    Davis, M.
    Eberly, S.
    Kayson, E.
    Whaley, J.
    Goldstein, J.
    Testa, C.
    MOVEMENT DISORDERS, 2017, 32
  • [5] Tetrabenazine in the management of motor symptoms of Huntington's disease: Long-term effect in a large series
    Fasano, A.
    Cadeddu, F.
    Guidubaldi, A.
    Bentivoglio, A.
    MOVEMENT DISORDERS, 2006, 21 : S361 - S361
  • [6] Long-term monitoring of the mortality trend of Huntington’s disease in Austria
    Eva Ekestern
    Gustav Lebhart
    European Journal of Epidemiology, 2005, 20 : 169 - 172
  • [7] Long-term monitoring of the mortality trend of Huntington's disease in Austria
    Ekestern, E
    Lebhart, G
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2005, 20 (02) : 169 - 172
  • [8] Long-term treatment of sleep breathing disorder in a patient with Huntington's disease
    Banno, K
    Hobson, DE
    Kryger, MH
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (04) : 261 - 264
  • [9] What are the long-term effects of neural grafting in patients with Huntington's disease?
    Isacson, Ole
    NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (09): : 470 - 471
  • [10] What are the long-term effects of neural grafting in patients with Huntington's disease?
    Ole Isacson
    Nature Clinical Practice Neurology, 2006, 2 : 470 - 471
12345